BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11188781)

  • 1. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
    Osterbor A
    Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact and management of anaemia in haematological malignancies.
    Coiffier B
    Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
    Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia in multiple myeloma.
    Ludwig H; Pohl G; Osterborg A
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in the anaemia of multiple myeloma and non-Hodgkin's lymphoma.
    San Miguel JF; García-Sanz R
    Med Oncol; 1998 Aug; 15 Suppl 1():S29-34. PubMed ID: 9785334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of human recombinant erythropoietin in children with cancer].
    Guyot D; Margueritte G
    Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of erythropoietin in patients with multiple myeloma.
    Egerer G; Harter C; Karthaus M; Ho AD; Goldschmidt H
    Onkologie; 2003 Feb; 26(1):80-4. PubMed ID: 12624523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rHuEPO and treatment outcomes: the preclinical experience.
    Ludwig H
    Oncologist; 2004; 9 Suppl 5():48-54. PubMed ID: 15591422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epoetin beta therapy in patients with solid tumours.
    Pronzato P; Jassem J; Mayordomo J
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy.
    Hedenus M; Näsman P; Liwing J
    J Clin Pharm Ther; 2008 Aug; 33(4):365-74. PubMed ID: 18613854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rHuEPO and treatment outcomes: the clinical experience.
    Hudis CA; Van Belle S; Chang J; Muenstedt K
    Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
    Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
    Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alfa-epoietin and anaemia in gynaecological cancer.
    Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
    Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F; Frère P; Fillet G; Beguin Y
    Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand.
    Roungrong J; Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S119-25. PubMed ID: 19255987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and infections in multiple myeloma: supportive therapy.
    Cáceres W; Santiago K; Paulo L; Román J
    Bol Asoc Med P R; 2009; 101(2):50-2. PubMed ID: 19954102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.